Cargando…

Predictive significance of TMRPSS2-ERG fusion in prostate cancer: a meta-analysis

BACKGROUND: Prostate cancer is a major malignancy in males. TMPRSS2-ERG is a high-frequency fusion gene expressed in prostate cancer and plays a vital role in carcinogenesis. Recent studies showed that TMPRSS2-ERG is a potential predictive biomarker for prostate cancer. However, the predictive value...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Chunjiao, Chen, Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233278/ https://www.ncbi.nlm.nih.gov/pubmed/30459527 http://dx.doi.org/10.1186/s12935-018-0672-2

Ejemplares similares

Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients
por: Abdel-Hady, Ahmed, et al.
Publicado: (2017)

Significance of the TMPRSS2:ERG gene fusion in prostate cancer
por: Wang, Zhu, et al.
Publicado: (2017)

Overview of research on fusion genes in prostate cancer
por: Song, Chunjiao, et al.
Publicado: (2020)

Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis
por: García-Perdomo, Herney Andrés, et al.
Publicado: (2018)

Leveraging artificial intelligence to predict ERG gene fusion status in prostate cancer
por: Dadhania, Vipulkumar, et al.
Publicado: (2022)

TMPRSS2-ERG fusion promotes prostate cancer metastases in bone
por: Deplus, Rachel, et al.
Publicado: (2016)

Dual TMPRSS2:ERG Fusion in a Patient with Lung and Prostate Cancers
por: Giunchi, Francesca, et al.
Publicado: (2020)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
por: Nam, R K, et al.
Publicado: (2007)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer
por: Li, Chengxun, et al.
Publicado: (2023)

Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancer
por: Kluth, Martina, et al.
Publicado: (2015)

Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
por: Lorenzin, Francesca, et al.
Publicado: (2022)

ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
por: Hashmi, Atif Ali, et al.
Publicado: (2019)

Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status
por: Dudka, Ilona, et al.
Publicado: (2020)

Comprehensive analysis of oncogenic signatures and consequent repurposed drugs in TMPRSS2:ERG fusion‐positive prostate cancer
por: Yun, Jae Won, et al.
Publicado: (2021)

Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer
por: Xu, Zhenyu, et al.
Publicado: (2018)

Research status and progress of the RNA or protein biomarkers for prostate cancer
por: Song, Chunjiao, et al.
Publicado: (2019)

TMPRSS2‐ERG fusions linked to prostate cancer racial health disparities: A focus on Africa
por: Blackburn, James, et al.
Publicado: (2019)

5′ UTR Control of Native ERG and of Tmprss2:ERG Variants Activity in Prostate Cancer
por: Zammarchi, Francesca, et al.
Publicado: (2013)

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
por: Furusato, B, et al.
Publicado: (2010)

Two paths for stabilization of ERG in prostate carcinogenesis: TMPRSS2-ERG fusions and speckle-type pox virus and zinc finger protein mutations
por: Pascal, Laura E, et al.
Publicado: (2016)

Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-κB Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer
por: Shao, Longjiang, et al.
Publicado: (2013)

Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors
por: Geybels, Milan S., et al.
Publicado: (2015)

Prostate cancer genes associated with TMPRSS2–ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts
por: Barwick, B G, et al.
Publicado: (2010)

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014)

TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
por: Hägglöf, Christina, et al.
Publicado: (2014)

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)

Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer
por: Lazzeri, Massimo, et al.
Publicado: (2022)

High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastases
por: Brandi, Franziska, et al.
Publicado: (2018)

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
por: Obinata, Daisuke, et al.
Publicado: (2014)

Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer
por: Kluth, Martina, et al.
Publicado: (2018)

Preliminary Results of Noninvasive Detection of TMPRSS2:ERG Gene Fusion in a Cohort of Patients With Localized Prostate Cancer
por: Tavukcu, Hasan Huseyin, et al.
Publicado: (2013)

Colorimetric TMPRSS2-ERG Gene Fusion Detection in Prostate Cancer Urinary Samples via Recombinase Polymerase Amplification
por: Koo, Kevin M., et al.
Publicado: (2016)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

Systematic Analysis of Cellular Signaling Pathways and Therapeutic Targets for SLC45A3:ERG Fusion-Positive Prostate Cancer
por: Kim, Jongsu, et al.
Publicado: (2022)

Gene signatures ESC, MYC and ERG-fusion are early markers of a potentially dangerous subtype of prostate cancer
por: Rye, Morten Beck, et al.
Publicado: (2014)

Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer
por: Xiao, Qingyu, et al.
Publicado: (2018)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

Molecular Composition of Genomic TMPRSS2-ERG Rearrangements in Prostate Cancer
por: Krumbholz, Manuela, et al.
Publicado: (2019)

Impact TMPRSS2–ERG Molecular Subtype on Prostate Cancer Recurrence
por: Kobelyatskaya, Anastasiya A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nvgcda00gpup2hjuhkoslpoofg